Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study.

Wolfhagen, F H; van Buuren, H R; den Ouden, J W; Hop, W C; van Leeuwen, J P; Schalm, S W; Pols, H A

Wolfhagen, F H; van Buuren, H R; den Ouden, J W; Hop, W C; van Leeuwen, J P; Schalm, S W; Pols, H A.

Affiliation

Wolfhagen FH; Department of Internal Medicine II (section Hepatology), University Hospital Rotterdam, The Netherlands.

J Hepatol ; 26(2): 325-30, 1997 Feb.

Article in En | MEDLINE | ID: mdl-9059953

Subject(s)

Adrenal Cortex Hormones/adverse effects; Etidronic Acid/therapeutic use; Liver Cirrhosis, Biliary/drug therapy; Osteoporosis/prevention & control; Adult; Aged; Bone Density/drug effects; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Etidronic Acid / Adrenal Cortex Hormones / Liver Cirrhosis, Biliary Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 1997 Type: Article Affiliation country: Netherlands

Search on Google

XML

PubMed Links